NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND Β2-Agonist OF INDACATEROL: PROSPECTS OF COBD THERAPY
Medical Council
doi 10.21518/2079-701x-2016-15-11-16
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Remedium, Ltd.